Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
Weill Medical College of Cornell University
22,068 participants
Feb 26, 2025
OBSERVATIONAL
Conditions
Summary
Phase 0 non-interventional longitudinal study of children and adults with Developmental and Epileptic Encephalopathy (DEE) due to a genetic cause. There are six arms of the study. Arms 1, 2, and 3 are devoted to one example DEE, MEF2C Haploinsufficiency Syndrome (MCHS). Arms 4, 5, and 6 are open to all DEE. Arm 1 (in-person) will enroll children 0 to 15, who will make in-person visits to Weill Cornell Medicine four times over two years. Arm 2 (virtual) will enroll people of all ages and older who will make virtual visits over Weill Cornell Zoom to Weill Cornell Medicine over two years (2 if 16 and older; 4 if 0 to 15). Arm 3 (registry) will enroll people of all ages in an online-only survey. Arms 4 - 6 mirror this structure but they are open to all children with DEE. Arm 4 (in-person) will enroll children of any age, who will make in-person visits every 6 months for 10 years. Arm 5 (virtual) will enroll children of any age for virtual visits, twice a year of 0 to 15, once a year if 16 or older. Arm 6 (registry) will enroll people of all ages in an online only survey.
Eligibility
Inclusion Criteria29
- Molecular diagnosis of a genetic disorder associated with DEE, as confirmed by the study investigators
- A neurological phenotype such as epilepsy or developmental delay as confirmed by the study investigators.
- English Speaking (Arms 1, 2, 4, 5). The registries may be completed by people who speak any language.
- ARM 1 (In person cohort)
- MEF2C
- Age 0 to 15 at the time of study enrollment.
- Willingness to travel to New York City four times over two years
- ARM 2 (Virtual cohort)
- MEF2C
- Any age at the time of study enrollment
- Sufficient internet connectivity to support video teleconferencing
- Commitment to fill out all survey instruments
- ARM 3 (Registry)
- MEF2C
- Any age at the time of study enrollment
- Commitment to fill out one on-line instrument
- ARM 4 (In person cohort)
- Any DEE
- Any age at the time of study enrollment
- Willingness to travel to New York City four times over two years
- ARM 5 (Virtual cohort)
- Any DEE
- Any age at the time of study enrollment
- Sufficient internet connectivity to support video teleconferencing
- Commitment to fill out all survey instruments
- ARM 6 (Registry)
- Any DEE
- Any age at the time of study enrollment
- Commitment to fill out one on-line instrument
Exclusion Criteria3
- Presence of a significant non-DEE-related central nervous impairment/behavioral disturbance that would confound the scientific rigor or interpretation of results of the study
- History of prematurity (defined as gestational age \<35 weeks), interventricular hemorrhage, structural brain deficit, or congenital heart disease
- Presence of a clinical comorbidity deemed by the investigator to potentially confound the typical presentation of DEE
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This intervention is observation only.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07413211